DexCom, Inc. (DXCM)
89.69
-0.45
(-0.50%)
USD |
NASDAQ |
Sep 02, 16:00
89.69
0.00 (0.00%)
After-Hours: 05:01
DexCom Research and Development Expense (TTM) : 604.00M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 604.00M |
| March 31, 2026 | 599.20M |
| December 31, 2025 | 599.10M |
| September 30, 2025 | 590.40M |
| June 30, 2025 | 568.30M |
| March 31, 2025 | 556.10M |
| December 31, 2024 | 552.40M |
| September 30, 2024 | 546.10M |
| June 30, 2024 | 542.10M |
| March 31, 2024 | 525.40M |
| December 31, 2023 | 502.90M |
| September 30, 2023 | 486.00M |
| June 30, 2023 | 464.90M |
| March 31, 2023 | 467.30M |
| December 31, 2022 | 484.20M |
| September 30, 2022 | 604.80M |
| June 30, 2022 | 623.30M |
| March 31, 2022 | 630.70M |
| December 31, 2021 | 604.20M |
| September 30, 2021 | 486.50M |
| June 30, 2021 | 445.40M |
| March 31, 2021 | 396.20M |
| December 31, 2020 | 359.90M |
| September 30, 2020 | 319.50M |
| June 30, 2020 | 298.50M |
| Date | Value |
|---|---|
| March 31, 2020 | 287.60M |
| December 31, 2019 | 273.50M |
| September 30, 2019 | 470.00M |
| June 30, 2019 | 453.40M |
| March 31, 2019 | 431.60M |
| December 31, 2018 | 417.40M |
| September 30, 2018 | 190.80M |
| June 30, 2018 | 184.00M |
| March 31, 2018 | 182.10M |
| December 31, 2017 | 185.40M |
| September 30, 2017 | 180.40M |
| June 30, 2017 | 181.00M |
| March 31, 2017 | 172.00M |
| December 31, 2016 | 156.10M |
| September 30, 2016 | 140.90M |
| June 30, 2016 | 161.80M |
| March 31, 2016 | 149.90M |
| December 31, 2015 | 137.50M |
| September 30, 2015 | 130.60M |
| June 30, 2015 | 85.20M |
| March 31, 2015 | 76.60M |
| December 31, 2014 | 70.10M |
| September 30, 2014 | 60.60M |
| June 30, 2014 | 52.00M |
| March 31, 2014 | 47.30M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Abbott Laboratories | 3.128B |
| Insulet Corp. | 345.90M |
| Baxter International, Inc. | 480.00M |
| Globus Medical, Inc. | 147.06M |
| Stryker Corp. | 1.606B |